Nalu Announces Publication of Results from COMFORT Randomized Controlled Trial (RCT) Demonstrating Sustained Pain Relief and Functional Improvements Over 24 Months
Link to Press Release The 24-month results of the COMFORT Peripheral Nerve...
We have many different opportunities for you to meet with Nalu experts throughout the year. Contact us here or reach out to your local Nalu
representative to RSVP.
NY & NJ Pain Medicine Congress
November 6-9, 2025 (Jersey City, NJ)
North American Neurological Society (NANS)
January 22-25, 2025 (Las Vegas, NV)
News
Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain and Neuroscience
Peripheral nerve stimulation (PNS) has evolved substantially over recent...
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Link to Boston Scientific Press Release Boston Scientific Corporation (NYSE: BSX)...
Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc
CARLSBAD, Calif. (BUSINESS WIRE) August 21, 2025 — Nalu Medical Inc.,...
CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives
CARLSBAD, Calif. (BUSINESS WIRE) August 6, 2025 — Nalu Medical, Inc., a...
Nalu Announces Publication of Results from COMFORT 2 Randomized Control Trial (RCT) Making Nalu the First Permanent PNS Device to Demonstrate Level-1 Clinical Evidence
CARLSBAD, Calif. (BUSINESS WIRE) Aug 5, 2025 –– The results of...
Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS Therapy
Nalu Medical Achieves National Payer Milestone with Aetna Coverage for PNS...
Nalu Announces Publication of the Largest Long-Term Report of Real-World Data (RWD) on a Permanent PNS Device
CARLSBAD, Calif. (BUSINESS WIRE) May 8, 2025 — Publication of the Nalu...
Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors
CARLSBAD, Calif. (BUSINESS WIRE) Apr 3, 2025 — Nalu Medical, Inc. (“Nalu”)...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI
CARLSBAD, Calif. (BUSINESS WIRE) Jan 21, 2025 — Nalu Medical announces the...
Nalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain Patients
CARLSBAD, Calif. (BUSINESS WIRE) Jan 8, 2025 — Nalu Medical, Inc. (“Nalu”),...
Nalu 1-Year PNS Data Show Durable Pain Relief and Significant Functional Improvement
CARLSBAD, Calif. (BUSINESS WIRE) Dec 3, 2024 — One-year data from the Nalu...
